PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-41.09%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-74.47%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-112.04%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-112.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-117.41%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-117.74%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-117.74%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.81%
Share reduction while MTDR is at 0.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.42%
Reduced diluted shares while MTDR is at 0.20%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
45.62%
Maintaining or increasing dividends while MTDR cut them. John Neff might see a strong edge in shareholder returns.
-7.43%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-26.65%
Negative FCF growth while MTDR is at 689.14%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-37.45%
Negative 10Y revenue/share CAGR while MTDR stands at 722.52%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
14.66%
5Y revenue/share CAGR under 50% of MTDR's 255.03%. Michael Burry would suspect a significant competitive gap or product weakness.
51.17%
3Y revenue/share CAGR under 50% of MTDR's 211.61%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-36.48%
Negative 10Y OCF/share CAGR while MTDR stands at 2629.82%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
388.56%
5Y OCF/share CAGR is similar to MTDR's 353.98%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
22.90%
3Y OCF/share CAGR under 50% of MTDR's 431.89%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-1248.98%
Negative 10Y net income/share CAGR while MTDR is at 2210.94%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-142.27%
Negative 5Y net income/share CAGR while MTDR is 298.44%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
6.64%
Below 50% of MTDR's 1270.68%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-68.37%
Negative equity/share CAGR over 10 years while MTDR stands at 116.95%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-45.73%
Negative 5Y equity/share growth while MTDR is at 110.33%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-57.09%
Negative 3Y equity/share growth while MTDR is at 20.02%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-79.76%
Cut dividends over 10 years while MTDR stands at 2481.49%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
162.09%
Dividend/share CAGR of 162.09% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
76.26%
3Y dividend/share CAGR of 76.26% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
46.22%
AR growth well above MTDR's 52.29%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
6.01%
Asset growth at 75-90% of MTDR's 7.16%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
-6.93%
We have a declining book value while MTDR shows 9.35%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.05%
We’re deleveraging while MTDR stands at 0.33%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
10.73%
SG&A growth well above MTDR's 18.09%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.